Talazoparib tosylate
≥99%
- Product Code: 102762
CAS:
1373431-65-2
| Molecular Weight: | 552.55 g./mol | Molecular Formula: | C₂₆H₂₂F₂N₆O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Talazoparib tosylate is primarily used in the treatment of certain types of breast, ovarian, prostate, and pancreatic cancers. It is specifically effective in patients with mutations in the BRCA1 and BRCA2 genes, which are involved in DNA repair. The compound works by inhibiting the PARP enzyme, preventing cancer cells from repairing their DNA and leading to their death. This targeted therapy is often employed when other treatments, such as chemotherapy, have not been effective. It is administered orally, making it convenient for patients, and is commonly used as a monotherapy or in combination with other anticancer agents. Its ability to selectively target cancer cells with minimal impact on healthy cells makes it a valuable option in precision medicine for cancer treatment.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | $415.52 |
+
-
|
| 0.005 | 10-20 days | $625.40 |
+
-
|
Talazoparib tosylate
Talazoparib tosylate is primarily used in the treatment of certain types of breast, ovarian, prostate, and pancreatic cancers. It is specifically effective in patients with mutations in the BRCA1 and BRCA2 genes, which are involved in DNA repair. The compound works by inhibiting the PARP enzyme, preventing cancer cells from repairing their DNA and leading to their death. This targeted therapy is often employed when other treatments, such as chemotherapy, have not been effective. It is administered orally, making it convenient for patients, and is commonly used as a monotherapy or in combination with other anticancer agents. Its ability to selectively target cancer cells with minimal impact on healthy cells makes it a valuable option in precision medicine for cancer treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :